Differential Gene Expression Profile of Human Neutrophils Cultured with Plasmodium falciparum-Parasitized Erythrocytes.
Malaria is one of the biggest public health problems globally, putting half of the world's population at risk of infection and killing nearly 0.5 million people annually. Plasmodium falciparum is the deadliest species of the parasite and is transmitted to humans by the mosquito Anopheles gambiae . Once within the human body, the parasites initiate the clinically silent liver stage and the blood stage, which is associated with the clinical manifestations. In severe infections, P. falciparum-parasitized erythrocytes (iRBCs) sequestrate in the blood microvessels causing disruption of the microvascular blood flow to vital organs. Other accompanying events in malaria pathophysiology include leukocyte adhesion to the microvasculature, systemic production of inflammatory cytokines, and cytotoxic lymphocyte activation. Severe malaria is more common in children and nonimmune individuals who may develop anemia, jaundice, systemic inflammation, metabolic acidosis, renal failure, respiratory distress, and cerebral or placental disorders. Repeated exposure to the infections elicits robust immunity that usually protects from severe infection and death [1-3]. Therefore, detailed knowledge on the mechanisms by which immune cells regulate the host immunity to and immunopathogenesis of malaria may aid in the development of novel control strategies.
Neutrophils are polymorphonuclear leukocytes (PMNs) that are generated in the bone marrow from myeloid precursors and live for only a short time in the circulation. They represent the most abundant leukocyte population in the blood that rapidly infiltrates sites of inflammation or infection, where they eliminate the invading microorganisms . PMNs eliminate pathogens intracellularly after phagocytizing them within their phagosomes using NADPH oxidase-dependent mechanisms and antibacterial proteins such as cathepsins, defensins, lactoferrin, and lysozymes. They can also eliminate microorganisms extracellularly by releasing neutrophil extracellular traps (NETs) that comprise a DNA element, antimicrobial histones, and proteases. In addition to their protective role, activated PMNs contribute to the pathogenesis of many inflammatory diseases by secreting an array of cytokines, chemokines, lipid mediators, myeloperoxidase, matrix metalloproteinases, and leukotrienes that mediate the initiation and progression of inflammation . Yet, despite being indispensable for maintaining host health, the role of PMNs in host resistance to and pathogenesis of malarial infection remains controversial. For instance, numerous in vitro and in vivo studies have shown that neutrophils play a protective role against malarial parasites [5-10]. On the other hand, the contribution of neutrophils to the pathogenesis of cerebral malaria or to the severity of malarial infection has only been demonstrated in mice [11-13]. Moreover, a recent study has shown that depletion of PMNs and blocking of NETs prevent the development of malaria-associated acute lung injury/acute respiratory distress syndrome and significantly increase mouse survival . Likewise, higher neutrophil numbers are present in peripheral blood of patients with severe malaria as compared to those in uncomplicated cases . In the current study, therefore, we analyzed the transcriptional profiling of human PMNs in response to iRBCs by using oligonucleotide microarrays as a step toward understanding the role of cells in the immunopathogenesis of malaria. Results revealed that the transcriptional response of PMNs to iRBCs includes upregulation of numerous genes encoding multiple surface receptors and proteins involved in signal transduction pathways, defense, and inflammatory responses.
2. Materials and Methods
2.1. Ethics Statement. Our protocols for the use of human peripheral blood erythrocytes and PMNs were approved by the Research Ethics Review Committee of the Obihiro University of Agriculture and Veterinary Medicine (approval number 2014-01), and experiments were conducted in accordance with the Fundamental Guidelines for Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology, Japan. Informed written consent to use the blood in this research was obtained from the donor.
2.2. Preparation of iRBCs and Neutrophils for Phagocytosis Assay. The Plasmodium falciparum 3D7 strain (Malaria Research and Reference Reagent Resource Center; MR4, American Type Culture Collection, Manassas, VA) was cultured and was enriched to [greater than or equal to]85% (Miltenyi Biotec, Auburn, CA, USA) for phagocytosis assay as previously described . The PMNs were isolated from the peripheral blood of a healthy donor using Ficoll-Paque[TM] PLUS (GE Healthcare). After centrifugation, mononuclear layer cells, plasma, Ficoll, and interface layer of RBC pellets with Ficoll were discarded and RBC pellets were suspended in RBC lysis buffer (Sigma) to obtain PMNs. Purity of isolated cells was determined by performing a differential blood cell count of Giemsa-stained smears. Purified PMNs contained <1% other types of cells including lymphocytes, monocytes, eosinophils, and basophils. Freshly isolated PMNs (1 x [10.sup.6]) were seeded onto poly-D-lysine-coated coverslips (Neuvitro, WA, USA) at 1 x 10 and then cocultured at 37[degrees]C in a humidified atmosphere containing 5% CO2 with either uninfected RBCs or enriched iRBCs (1:20) for 1 h in the presence of 250ng/ml human recombinant IFN-[gamma] (R&D Systems). Cells were obtained at different time points from the same donor to minimize nonspecific reactions of neutrophils with the erythrocytes. All experiments on PMNs were carried out within 4 h after collection of blood. Control cells were cultured in the same medium supplemented with 250 ng/ml IFN-[gamma] and uninfected RBCs (1 : 20). The percentage of phagocytosis was calculated based on the number of PMNs phagocytizing iRBCs or malaria pigment relative to the total number of PMNs on the coverslips stained with 10% Giemsa solution (Sigma) for 30min . To detect NETs, adherent PMNs were cocultured with iRBCs on glass coverslips for 1 h and then observed after immunostaining by means of confocal microscopy. Briefly, the coverslips were gently washed three times with PBS, fixed with 4% paraformaldehyde solution for 20 min at 4[degrees]C, and then treated with 0.3% Triton[TM] X100 (Sigma) in PBS for 5 min for cell permeabilization. The primary antibody (anti-PfEXP2) for malarial parasite staining was diluted (1 : 1000) in PBS-3% fetal calf serum and incubated with the coverslips for 1h at 37[degrees]C in a moist chamber. Alexa-Fluor[R] 488-conjugated goat anti-rabbit IgG (Molecular Probes, Invitrogen, Carlsbad, CA, USA) was used as the secondary antibody at a dilution of 1 : 400 to specifically label the first antibody for 30 min at 37[degrees]C. Hoechst was used to label the nuclear DNA and the NETs released from the cells (Molecular Probes). Finally, the coverslips were washed with PBS and mounted (Dako, Denmark) for analysis by a confocal laser scanning microscope (TCS NT, Leica, Heidelberg, Germany).
2.3. Microarray Analysis and Data Analysis. PMNs cultured with RBCs or iRBCs for 1 h were washed with ice-cold PBS and lysed with TRIzol Reagent (Invitrogen), and RNA samples were extracted using the RNeasy Plus Mini kit (Qiagen) according to the manufacturer's instructions. The experiment was performed in quadruplicate for each condition. High-quality RNA samples with integrity values of >7.0 (Agilent 2100 Bioanalyzer, Agilent Technologies) were subjected to microarray analysis . Microarray data are available at the Gene Expression Omnibus (GEO) database (http:www.ncbi.nlm.nih.gov/geo/) under the accession number GSE114076.
2.4. Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR). cDNAs were synthesized from total RNA by using first-strand cDNA (Invitrogen) with oligo-dT primers, according to the manufacturer's instructions. The expression of target genes was analyzed by qRT-PCR as previously described . The specific primers used in this study are listed in Supplementary Materials (Table S1).
2.5. Data Analysis. For the microarray data analysis, each gene expression array data set was normalized to the in silico pool for the neutrophils cocultured with RBCs. Differentially expressed genes with at least a 2.0-fold difference in expression that was statistically significant (p <0.01) relative to the expression level in the neutrophils cocultured with RBCs were assigned to a Gene Ontology group to identify the biological functions that were enriched in the gene set. Statistically significant differences in gene expression between the PMNs cocultured with RBCs and those cocultured with iRBCs were determined by using a moderated t-test (p <0.01). Enrichment of genes into GO terms for molecular function, biological processes, pathways, and interaction networks was achieved by using Genomatix GeneRanker (http://www.genomatix.de/), DAVID 6.7 (http://david.abcc. ncifcrf.gov), NET-GE (http://net-ge.biocomp.unibo.it/enrich), and Enricher (http://amp.pharm.mssm.edu/Enrichr/). Significant enrichment for each GO term was determined by a multiple testing correction method (p <0.05).
3. Results and Discussion
Freshly isolated PMNs exhibited high phagocytic activity to iRBCs in medium supplemented with human noninfected serum and recombinant IFN-[gamma], which peaked within the 1st hour of culture (Figures 1(a) and 1(b)). Of note, a few NETs were observed in the PMN cultures with iRBCs but not in the PMN cultures with RBCs (Figure 1(c)). No phagocytic activity and NET formation were observed in neutrophil cultures with normal RBCs (data not shown). Surprisingly, phagocytic activity of these cells sharply declined in the 2nd hour of culture with iRBCs (data not shown). These results disagreed with earlier study reporting that activity of PMNs is dependent on the presence of malaria-immune serum in the medium . The high phagocytic activity noted in our study can be explained by the fact that we used a high ratio of iRBCs in the assay, which increased the interaction with the cells and promoted phagocytic activity of PMNs. In addltion, primed neutrophils by IFN-[gamma] exhibit an elevation in their phagocytic activity in vitro in the absence of malariaimmune serum [6, 7]. Generally, the interaction between iRBCs with human peripheral blood mononuclear cells leads to a nonspecific stimulation of lymphocytes and a release of cytokines that facilitate and stimulate the interaction between iRBCs and other immune cells . Therefore, addition of IFN-[gamma] to PMN cultures is to mimic the priming status of PMNs during early-stage infection of malaria and to promote their interaction with iRBCs. Intraleukocytic iRBCs were observed after 15-30 min incubation, while intraleukocytic pigments were predominantly seen after 1 h incubation (Figures 1(a) and 1(b)). These results suggested that PMNs can rapidly lyse the phagocytized iRBCs within their phagolysosomes. This may explain the predominance of intraleukocytic pigments within PMNs in blood smears of field studies. Together, our findings are consistent with previous reports noting that the response of PMNs to iRBCs is rapid and includes phagocytosis and NET formation [7, 14, 19]. These data support the concept that PMNs rapidly respond to the invasion of protozoan parasites, including Toxoplasma gondii and Leishmania amazonensis, through promoting phagocytosis and NETosis [20-22].
To further gain insights into the molecular response of neutrophils phagocytizing iRBCs, we performed gene transcriptional analyses by using oligonucleotide-based DNA mlcroarrays. Of 56,689 probes tested, 334 were statistically significantly differentially regulated (fold change > 2.0, p < 0.01); 118 and 216 probes were up- and downregulated, respectively, in PMNs cultured with iRBCs compared to the same probes in PMNs cultured with RBCs (Figure 1(d)). It is worth noting that a number of upregulated genes in PMNs phagocytizing iRBCs including BATF2, CISH, FCGR1A, SOCS3, CXCL10, HAS1, IRG1, IL1A, ELN, and CTSL are known to be involved in various inflammatory diseases . To validate these transcriptional findings, the gene expression of randomly selected genes, including RIT2, MLLT10, CTSL, CYGB, ELN, SOCS3, IRG1, VIT, CISH, and CXCL10, was examined by qRT-PCR. The fold changes in gene expression determined by these two assays were somehow comparable with some differences in magnitude (Table 1).
To determine whether neutrophils in response to iRBCs elicit a specific gene expression profile, we compared our data to transcriptional microarray results of neutrophils stimulated by LPS . Venn diagram analysis revealed that 6 upregulated genes (CISH, ERLIN1, FCRL1, IL1A, RPS6KA2, and SOCS3) and 9 downregulated genes (ADORA3, ARRDC3, BCOR, ERN1, FRAT1, HBB, KLHDC8B, TIGD3, and ZNF217) were present in the responses of neutrophils to either iRBC or LPS stimulation (Figures 1(d) and 1(e)). The discrepancies in the responses of PMNs to these stimuli are most likely due to distinct receptors and signaling pathways associated with each stimulus. Toll-like receptor 4 is the major LPS receptor that leads to the activation of the transcriptional regulator NF-[kappa]B in neutrophils . On the other hand, TLR7 seems to play a central role in early immune activation during malaria infection and is required for proinflammatory cytokine production and immune cell activation during the peak of parasitemia . Given the possibility that the low percentage of the contaminating cells including monocytes in the PMN fraction may lead to incorrect results , we further compared the gene profile of PMNs to that of macrophages phagocytizing iRBCs . Intriguingly, only the RIT2 gene was present in the responses of neutrophils and macrophages to iRBCs. However, the gene expression of RIT2 in PMNs was 156 times greater than that in macrophages phagocytizing iRBCs. Together, the transcriptional responses of PMNs associated with phagocytizing iRBCs included upregulation of surface receptors, signal transduction pathways, and inflammatory cytokines, which might reflect their roles in the pathogenesis during malaria infection.
To further determine the functional and biological relevance of the regulated genes, enrichment analyses according to Gene Ontology (GO) specifications were carried out. Gene sets were categorized into multiple molecular functional groups, including kinase regulator activity, signal transducer activity, receptor activity, molecular transducer activity and carbohydrate derivative binding, cytokine receptor activity, and glycoprotein binding activity (Figure 2(a) and Table S2). Moreover, upregulated genes in PMNs phagocytizing iRBCs were categorized into multiple biological processes including cellular response to cytokine stimulus, cytokine-mediated signaling pathway, response to cytokine, signaling, regulation of the cellular process, cell communication, defense response, response to stimulus, and biological regulation (Figure 2(a) and Table S2). Of note, cytokine receptor activity and defense response were the most significantly enriched terms in PMNs phagocytizing iRBCs based on network enrichment analysis for molecular function or biological process, respectively (Figure 2(b)). Downregulated genes of PMNs phagocytizing iRBCs were mainly involved in oxygen binding, apoptosis, and metabolic processes (Table S3). Furthermore, functional pathway analysis was performed to define the relevant biological pathways involved in PMN responses to iRBCs. This analysis identified 5 statistically significant pathways including mitogen-activated protein kinase (MAPK), insulin receptor, Jak-STAT signaling pathway, interleukin signaling pathway, and interferon-gamma signaling pathway (Figure 2(c) and Table 2). In an analogous fashion, the IFN-[gamma] signaling pathway was the most significantly enriched term in the gene signature of neutrophils infected with Mycobacterium tuberculosis , and MAPK, Jak-STAT, and interleukin signaling pathways are the most significantly enriched pathways in the primed human neutrophils by proinflammatory cytokines including TNF-[alpha] and GM-CSF . On the other hand, the downregulated genes clustered in two pathways relevant to nuclear factor and lymphoid enhancer-binding factor (data not shown). To gain an insight into the regulation of signaling pathways involved in PMN response to iRBCs, transcription factor (TF) enrichment analysis for upregulated genes was performed using TF-protein-protein interactions (PPIs). Results showed that POU domain, class 4, transcription factor 1 (POU4F1: CCT3, MLLT10, MGA, KRT14, and FLNA) and POU5F1 (RIT2) are the most significantly (p = 0.01671 and 0.04158, resp.) enriched TF.
Our microarray data revealed that PMNs express a number of cell surface receptors for the recognition of iRBCs, including protein G receptors (P2RY4, GPR88, MRGPRG, FFAR3, HCAR1, and MRGPRF), adhesion receptors (VIT, CD69), sialic acid (SIGLEC12), Fc receptors (FCGR1a, FCRL1), FLNA, and IL-15RA. In general, priming of immune response to malaria is critically dependent on the activation of innate immune cells through their receptors including Toll-like receptors (TLRs), scavenger receptors, and the NOD-like receptor-containing pyrin domain 3 (NLRP3) inflammasome. Consequent activation of these receptors triggers distinct transcriptional pathways that lead to pathogen clearance [29, 30]. Our bioinformatics analysis revealed that the most upregulated genes of PMNs induced by iRBC phagocytosis included genes involved in MAPK signal transduction, which is known to be involved in cell proliferation, differentiation, stress responses, apoptosis, immune defense, and cytokine biosynthesis [29, 31]. Moreover, the gene profile of PMNs phagocytizing iRBCs indicated that the RIT2 gene was the top-regulated gene. RIT2, a member of the Ras superfamily, is a small molecular weight GTP-binding protein localized on the plasma membrane and is involved in the signaling of diverse biological processes including cell growth, differentiation, survival, senescence, and motility. The RIT2 gene is specifically expressed in neurons and plays a critical role in neuronal differentiation by mediating the magnitude and longevity of the MAPK cascade . The regulation of RIT2 in neutrophils in response to iRBCs might probably sustain the activation of the MAPK signaling cascade needed for the senescence, motility, and cytokine production. Our next study is to elucidate the possible mechanism by which RIT2 maintains the phagocytic activity of neutrophils in response to malarial parasites. Our data corroborate previous findings from transcriptional analyses of whole-blood transcriptomes of Malawian patients infected with P. falciparum which revealed that the expression of numerous genes involved in MAPK signaling and inflammatory cytokine pathways is modified in response to P. falciparum exposure .
Other pathways that were upregulated in response of PMNs to iRBCs included interleukin and IFN-[gamma] signaling pathways, which play an essential role in priming innate immune cells and promoting proinflammatory responses during malaria infection [33-35]. Nonetheless, excessive systemic production of inflammatory cytokines results in severe pathogenesis and poor outcome of infection [3,35]. Our data showed the involvement of IL-1A, CXCL10, SOCS3, and CISH in the early response of PMNs to iRBCs, which are known to be associated with susceptibility to severe malaria infection [36-39]. Importantly, our previous study showed that macrophages phagocytizing iRBCs downregulate the expression of CXCL10 compared to control macrophages cultured with noninfected RBCs . This may suggest that neutrophils but not macrophages are an important source of CXCL10, which is known to promote severe malaria by enhancing the recruitment of inflammatory cells and leukocyte activation . On the other hand, SOCS3 and CISH are members of the suppressor of cytokine signaling (SOCS) family that mediate the regulation of cytokine receptor signaling and are implicated in a broad range of infectious diseases such as bacteremia and tuberculosis . Together, our data showed that the gene profile of PMNs phagocytizing iRBCs is typified by the elevation of a number of transcripts involved in pathogenesis of malaria.
Our current study revealed that the responses of neutrophils to iRBCs are initiated by multiple surface receptors that consequently lead to the activation of distinct signaling pathways. This response includes the activation of a number of proinflammatory and regulatory cytokines, as well as of chemokines that may mediate the severity of the disease. These data improve our understanding of the early transcriptional events that occur in neutrophils in response to iRBCs and may aid in the identification of rational targets for future therapeutic interventions.
The data used to support the findings of this study are available from the corresponding author upon request.
Conflicts of Interest
The authors declare that they have no competing interests.
This work was supported by grants-in-aids for young scientlsts (Wakate B, 15K20840); by grants-in-aids for exploratory scientific research on innovative areas (3308 and 3407) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and for research on global health issues from the Ministry of Health, Labour and Welfare, Japan; by the Bio-oriented Technology Research Advancement Institution (BRAIN); by the Kanae Foundation for the Promotion of Medical Science; and by the Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST). The authors thank Professor Takafumi Tsubol (Ehime University) for providing the specific antibody to PfEXP2 for detecting human malarial parasites.
Table S1: primers used in this study. Table S2: GO terms for molecular function and biological process of the genes upregulated in PMNs phagocytizing iRBCs. Table S3: GO terms for molecular function and biological process of the genes downregulated in PMNs phagocytizing iRBCs. (Supplementary Materials)
 WHO, "WHO Global Malaria Programme: the world malaria report 2015," World Health Organization, 2015, http:// www.who.int/mediacentre/factsheets/fs094/en/.
 L. H. Miller, H. C. Ackerman, X. Z. Su, and T. E. Wellems, "Malaria biology and disease pathogenesis: insights for new treatments," Nature Medicine, vol. 19, no. 2, pp. 156-167, 2013.
 L. Schofield and G. E. Grau, "Immunological processes in malaria pathogenesis," Nature Reviews Immunology, vol. 5, no. 9, pp. 722-735, 2005.
 A. Mocsai, "Diverse novel functions of neutrophils in immunity, inflammation, and beyond," The Journal of Experimental Medicine, vol. 210, no. 7, pp. 1283-1299, 2013.
 A. Porcherie, C. Mathieu, R. Peronet et al., "Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria," The Journal of Experimental Medicine, vol. 208, no. 11, pp. 2225-2236, 2011.
 L. M. Kumaratilake, A. Ferrante, and C. Rzepczyk, "Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum," Infection and Immunity, vol. 58, no. 3, pp. 788-793, 1990.
 L. M. Kumaratilake, A. Ferrante, and C. Rzepczyk, "The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects," The Journal of Immunology, vol. 146, no. 2, pp. 762-767, 1991.
 C. Joos, L. Marrama, H. E. J. Polson et al., "Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies," PLoS One, vol. 5, no. 3, article e9871, 2010.
 C. Pierrot, E. Adam, D. Hot et al., "Contribution of T cells and neutrophils in protection of young susceptible rats from fatal experimental malaria," Journal of Immunology, vol. 178, no. 3, pp. 1713-1722, 2007.
 F. M. d. S. Leoratti, S. C. Trevelin, F. Q. Cunha et al., "Neutrophil paralysis in Plasmodium vivax malaria," PLoS Neglected Tropical Diseases, vol. 6, no. 6, article e1710, 2012.
 A. Mahanta, S. K. Kar, S. Kakati, and S. Baruah, "Heightened inflammation in severe malaria is associated with decreased IL-10 expression levels and neutrophils," Innate Immunity, vol. 21, no. 5, pp. 546-552, 2015.
 L. Chen, Z. H. Zhang, and F. Sendo, "Neutrophils play a critical role in the pathogenesis of experimental cerebral malaria," Clinical and Experimental Immunology, vol. 120, no. 1, pp. 125-133, 2000.
 B. C. Rocha, P. E. Marques, F. M. . S. Leoratti et al., "Type I interferon transcriptional signature in neutrophils and lowdensity granulocytes are associated with tissue damage in malaria," Cell Reports, vol. 13, no. 12, pp. 2829-2841, 2015.
 M. K. Sercundes, L. S. Ortolan, D. Debone et al., "Correction: targeting neutrophils to prevent malaria-associated acute lung injury/acute respiratory distress syndrome in mice," PLoS Pathogens, vol. 13, no. 11, article e1006730, 2017.
 C. M. Feintuch, A. Saidi, K. Seydel et al., "Activated neutrophils are associated with pediatric cerebral malaria vasculopathy in Malawian children," MBio, vol. 7, no. 1, pp. e01300-e01315, 2016.
 M. A. Terkawi, R. Takano, and K. Kato, "Isolation and cocultivation of human macrophages and neutrophils with Plasmodium falciparum-parasitized erythrocytes: an optimized system to study the phagocytic activity to malarial parasites," Parasitology International, vol. 65, no. 5, Part B, pp. 545-548, 2016.
 M. A. Terkawi, R. Takano, A. Furukawa, F. Murakoshi, and K. Kato, "Involvement of [beta]-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparum," Scientific Reports, vol. 7, article 41772, 2017.
 A. Ferrante, R. E. Staugas, B. Rowan-Kelly et al., "Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria and malarial parasites," Infection and Immunity, vol. 58, no. 12, pp. 3996-4003, 1990.
 V. S. Baker, G. E. Imade, N. B. Molta et al., "Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age," Malaria Journal, vol. 7, no. 1, p. 41, 2008.
 D. S. Abi Abdallah, C. Lin, C. J. Ball, M. R. King, G. E. Duhamel, and E. Y. Denkers, "Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps," Infection and Immunity, vol. 80, no. 2, pp. 768-777, 2012.
 L. M. R. Silva, T. Munoz Caro, R. Gerstberger et al., "The apicomplexan parasite Eimeria arloingi induces caprine neutrophil extracellular traps," Parasitology Research, vol. 113, no. 8, pp. 2797-2807, 2014.
 A. B. Guimaraes-Costa, M. T. C. Nascimento, G. S. Froment et al., "Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 16, pp. 6748-6753, 2009.
 H. L. Wright, H. B. Thomas, R. J. Moots, and S. W. Edwards, "RNA-seq reveals activation of both common and cytokinespecific pathways following neutrophil priming," PLoS One, vol. 8, no. 3, article e58598, 2013.
 S. de Kleijn, M. Kox, I. E. Sama et al., "Transcriptome kinetics of circulating neutrophils during human experimental endotoxemia," PLoS One, vol. 7, no. 6, article e38255, 2012.
 P. P. McDonald, A. Bald, and M. A. Cassatella, "Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils," Blood, vol. 89, no. 9, pp. 3421-3433, 1997.
 A. Baccarella, M. F. Fontana, E. C. Chen, and C. C. Kim, "Toll-like receptor 7 mediates early innate immune responses to malaria," Infection and Immunity, vol. 81, no. 12, pp. 4431-4442, 2013.
 M. S. Davey, N. Tamassia, M. Rossato et al., "Failure to detect production of IL-10 by activated human neutrophils," Nature Immunology, vol. 12, no. 11, pp. 1017-1018, 2011.
 M. P. R. Berry, C. M. Graham, F. W. McNab et al., "An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis," Nature, vol. 466, no. 7309, pp. 973-977, 2010.
 K. Futosi, S. Fodor, and A. Mocsai, "Neutrophil cell surface receptors and their intracellular signal transduction pathways," International Immunopharmacology, vol. 17, no. 3, pp. 638650, 2013.
 R. T. Gazzinelli, P. Kalantari, K. A. Fitzgerald, and D. T. Golenbock, "Innate sensing of malaria parasites," Nature Reviews Immunology, vol. 14, no. 11, pp. 744-757, 2014.
 Y. Liu, E. G. Shepherd, and L. D. Nelin, "MAPK phosphatases-regulating the immune response," Nature Reviews Immunology, vol. 7, no. 3, pp. 202-212, 2007.
 G. X. Shi, J. Han, and D. A. Andres, "Rin GTPase couples nerve growth factor signaling to p38 and b-Raf/ERK pathways to promote neuronal differentiation," Journal of Biological Chemistry, vol. 280, no. 45, pp. 37599-37609, 2005.
 C. F. Ockenhouse, W. C. Hu, K. E. Kester et al., "Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria," Infection and Immunity, vol. 74, no. 10, pp. 5561-5573, 2006.
 B. S. Franklin, P. Parroche, M. A. Ataide et al., "Malaria primes the innate immune response due to interferon-y induced enhancement of toll-like receptor expression and function," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 14, pp. 5789-5794, 2009.
 A. J. Walley, C. Aucan, D. Kwiatkowski, and A. V. S. Hill, "Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study," European Journal of Human Genetics, vol. 12, no. 2, pp. 132-138, 2004.
 N. H. Hunt and G. E. Grau, "Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria," Trends in Immunology, vol. 24, no. 9, pp. 491-499, 2003.
 L. J. Ioannidis, C. Q. Nie, and D. S. Hansen, "The role of chemokines in severe malaria: more than meets the eye," Parasitology, vol. 141, no. 05, pp. 602-613, 2014.
 C. C. Khor, F. O. Vannberg, S. J. Chapman et al., "CISH and susceptibility to infectious diseases," The New England Journal of Medicine, vol. 362, no. 22, pp. 2092-2101, 2010.
 F. Brant, A. S. Miranda, L. Esper et al., "Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection," Infection and Immunity, vol. 82, no. 8, pp. 3127-3140, 2014.
 L. J. Ioannidis, C. Q. Nie, A. Ly, V. Ryg-Cornejo, C. Y. Chiu, and D. S. Hansen, "Monocyte- and neutrophil-derived CXCL10 impairs efficient control of blood-stage malaria infection and promotes severe disease," Journal of Immunology, vol. 196, no. 3, pp. 1227-1238, 2016.
 M. C. Trengove and A. C. Ward, "SOCS proteins in development and disease," American Journal of Clinical and Experimental Immunology, vol. 2, no. 1, pp. 1-29, 2013.
Mohamad Alaa Terkawi, (1,2) Ryo Takano, (1) and Kentaro Kato (ID) (1,3)
(1) National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Inada- cho, Obihiro, Hokkaido 080-8555, Japan
(2) Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita- 15, Nish-7, Kita-ku, Sapporo 060-8638, Japan
(3) Research Center for Global Agromedicine, Obihiro University of Agriculture and Veterinary Medicine, Inada-cho, Obihiro, Hokkaido 080-8555, Japan
Correspondence should be addressed to Kentaro Kato; email@example.com
Received 31 January 2018; Revised 8 May 2018; Accepted 15 May 2018; Published 5 July 2018
Academic Editor: Baohui Xu
Caption: Figure 1: Response of human PMNs to iRBCs. (a) Percentage of PMNs phagocytizing iRBCs at different time points of incubation. Each bar represents the mean [+ or -] SEM for each group (n = 4). (b) Neutrophils phagocytizing iRBCs or malaria pigment as stained by Giemsa. Arrows indicate phagocytized iRBCs or pigment. Freshly isolated neutrophils were cultured with enriched iRBCs onto coverslips, and their phagocytic activity was examined at different time points after staining with Giemsa. (c) PMNs phagocytizing iRBCs (upper panels) and releasing NETs after coculture with iRBCs (lower panels). PMNs on the coverslips were stained with specific antibodies and examined by means of confocal microscopy. The scale bar is indicated on each image. (d) Gene profile of human neutrophils as assessed by microarray analysis. Clusters of downregulated genes and upregulated genes of neutrophils cultured for 1 h with human nonparasitized RBCs or enriched iRBCs (n = 4). (e) Venn diagram analyses for the comparison genes regulated in PMNs after stimulation with iRBCs or LPS. The upper panel is for upregulated genes, and the lower panel for downregulated genes. (f) Venn diagram analyses for the comparison genes regulated in macrophages and PMNs phagocytizing iRBCs.
Caption: Figure 2: GO enrichment analyses of significantly differentially expressed genes of neutrophils in response to iRBCs. (a) Gene sets were categorized according to molecular function (upper panel) and biological processes (lower panel). (b) Network-based gene enrichment of the most significantly enriched terms for molecular function and biological processes. The annotation modules based on STRING for GO terms and multiple testing correction methods (p < 0.05) were performed based on NET-GE tools. (c) Biological pathways enriched in upregulated genes involved in the neutrophil response to iRBCs.
Table 1: Changes in gene expression in neutrophils phagocytizing iRBCs as determined by DNA microarray analysis and qRT-PCR. Gene GenBank Fold changef ([dagger]) accession number Microarray qRT-PCR RIT2 NM_002930 780.63 51.35 [+ or -] 14.44 MLLT10 NM_004641 287.92 6.20 [+ or -] 2.67 CTSL NM_001912 87.55 41.10 [+ or -] 26.38 CYGB NM_134268 39.87 9.65 [+ or -] 5.92 ELN NM_000501 39.86 30.72 [+ or -] 19.00 SOCS3 NM_003955 37.19 6.90 [+ or -] 2.70 IRG1 NM_001258406 22.05 5.39 [+ or -] 1.80 VIT NM_053276 18.94 8.41 [+ or -] 4.30 CISH NM_145071 18.19 24.65 [+ or -] 3.22 CXCL10 NM_001565 17.69 10.83 [+ or -] 7.63 CD64 XM_005244958 10.56 8.24 [+ or -] 1.30 ([dagger]) Fold change indicates the mean expression level of the gene in neutrophils cocultured with Plasmodium falciparum-parasitized erythrocytes normalized to that in neutrophils cocultured with normal red blood cells. Table 2: Enriched pathways for the upregulated genes in PMNs phagocytizing iRBCs. Pathway Count p value Genes Mitogen-activated 8 0.000442 HCAR1, RPS6KA2, protein kinase PEBP4, RIT2, (hsa04010) MAPK8IP2, MLLT10, CDK5RAP1, HAS1 Insulin receptor 4 0.000793 LETM1, CISH, RIT2, (hsa04910) SOCS3 Jak-STAT signaling 5 0.000731 BATF2, CISH, SOCS3, pathway (hsa04630) MLLT10, CXCL10 Interleukin 4 0.00139 IL1A, IL15RA, NOS3, signaling pathway RPS6KA2 (P00970) Interferon-gamma 2 0.02225 SOCS3, CISH signaling pathway (P00035)
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Terkawi, Mohamad Alaa; Takano, Ryo; Kato, Kentaro|
|Publication:||Journal of Immunology Research|
|Date:||Jan 1, 2018|
|Previous Article:||Sevoflurane Inhibits the Th2 Response and NLRP3 Expression in Murine Allergic Airway Inflammation.|
|Next Article:||Investigation of Outbreak-Specific Nonsynonymous Mutations on Ebolavirus GP in the Context of Known Immune Reactivity.|